MABVAX THERAPEUTICS HOLDINGS, INC.·4

Feb 23, 3:48 PM ET

MAFFUID PAUL W 4

4 · MABVAX THERAPEUTICS HOLDINGS, INC. · Filed Feb 23, 2018

Insider Transaction Report

Form 4
Period: 2018-02-21
Transactions
  • Award

    Option to Purchase Common Stock

    2018-02-21+195,000195,000 total
    Exercise: $2.04Exp: 2028-02-21Common Stock (195,000 underlying)
Footnotes (2)
  • [F1]Option award is partial compensation for service as an officer.
  • [F2]The Option Shares shall vest 25% at the 6-month anniversary of the commencement date; with the balance vesting in equal monthly amounts of 4.167% per month over the remaining 18 months until fully vested after 2 years from the commencement date.

Documents

1 file
  • 4
    form4-02232018_120245.xmlPrimary